首页> 外文期刊>BMC Clinical Pathology >The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
【24h】

The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

机译:细胞角蛋白7和20(CK7 / 20)免疫组织化学在区分短节段Barrett食管和胃肠上皮化生中的作用:是否可靠?

获取原文
           

摘要

Background The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric cardia and corpus. Methods Two groups of endoscopic biopsy specimens were examined, including 20 endoscopic biopsy specimens of short-segment Barrett esophagus (Group A) and equal number exhibiting Helicobacter pylori associated intestinal metaplasia of the gastric cardia and corpus (Group B). All were investigated by immunohistochemistry using the standard ABC method for CK7 and CK20 expression. Fisher's exact test was used for statistical analysis of Barrett CK7/20 and gastric CK7/20 patterns between the groups. Results The anticipated pattern of reactivity in Barrett mucosa (CK7: strong diffuse positivity in superficial and deep glands; CK20: positivity in surface epithelium and superficial glands) was seen in 2 cases of Group A specimens. The expected gastric pattern (CK7: patchy immunostaining with variable involvement of deep glands; CK20: patchy immunostaining of superficial and deep glands in incomplete intestinal metaplasia / absence of CK7 immunoreactivity with strong CK20 staining in superficial and deep glands in complete intestinal metaplasia) was seen in 8 cases of Group B specimens. The respective sensitivity and false-negativity values of CK7/20 staining for Barrett pattern in Group A were 10% and 90%, respectively. These values for gastric pattern in Group B were 40% and 60%, respectively. The specificity and false-positivity values of both patterns were same (100% and 0%, respectively). There was no statistically significant difference for Barrett pattern between the two groups (P = 0.487), while the observation of gastric pattern was significantly higher in Group B than in Group A (P = 0.02). Conclusions We concluded that these hypothesized and recently applied diagnostic criteria involving CK7 and CK20 immunoreactivity are not reliable in distinguishing short-segment Barrett esophagus from intestinal metaplasia as seen in gastric cardia and corpus.
机译:背景技术本相关免疫组织化学研究的目的是评估细胞角蛋白(CK7和CK20)表达在诊断短节段Barrett食道中的实用性,尤其是其在区分Barrett粘膜和胃card门和胃肠上皮化生中的功效。方法检查两组内窥镜活检标本,包括短节段Barrett食管的20张内窥镜活检标本(A组)和相等数量的表现出幽门螺杆菌相关的胃card体和胃肠化生的标本(B组)。使用标准ABC方法通过免疫组织化学对CK7和CK20的表达进行了所有研究。 Fisher精确检验用于两组之间Barrett CK7 / 20和胃CK7 / 20模式的统计分析。结果在2组A组标本中发现了Barrett粘膜的预期反应模式(CK7:在浅表和深部腺体中弥漫阳性; CK20:在表面上皮和表皮腺体中呈阳性)。观察到了预期的胃部模式(CK7:深部腺体累及的斑片状免疫染色; CK20:肠不完全化生的浅表层和深腺的斑片状免疫染色/完全肠化生的浅表和深部腺体中无CK7免疫反应性和强CK20染色) B组标本8例。 A组Barrett模式的CK7 / 20染色的敏感性和假阴性率分别为10%和90%。 B组的胃模式值分别为40%和60%。两种模式的特异性和假阳性值均相同(分别为100%和0%)。两组之间的Barrett模式没有统计学上的显着差异(P = 0.487),而B组的胃模式观察显着高于A组(P = 0.02)。结论我们得出的结论是,这些假想的和最近应用的涉及CK7和CK20免疫反应性的诊断标准不能可靠地将短节段Barrett食道与肠化生区分开,如在胃card门和体中所见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号